Search

Maria Marvich

Examiner (ID: 9363)

Most Active Art Unit
1633
Art Unit(s)
1633, 1634, 1631, 1636
Total Applications
1459
Issued Applications
618
Pending Applications
253
Abandoned Applications
627

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5552335 [patent_doc_number] => 20090286321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS' [patent_app_type] => utility [patent_app_number] => 12/363498 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 65754 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286321.pdf [firstpage_image] =>[orig_patent_app_number] => 12363498 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/363498
METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS Jan 29, 2009 Abandoned
Array ( [id] => 5421956 [patent_doc_number] => 20090148411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'VIRAL VECTOR-BASED GENE THERAPY METHODS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/363454 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 65737 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148411.pdf [firstpage_image] =>[orig_patent_app_number] => 12363454 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/363454
VIRAL VECTOR-BASED GENE THERAPY METHODS AND COMPOSITIONS Jan 29, 2009 Abandoned
Array ( [id] => 5422494 [patent_doc_number] => 20090148949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'rAAV Expression Systems and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/363469 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 65746 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148949.pdf [firstpage_image] =>[orig_patent_app_number] => 12363469 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/363469
rAAV Expression Systems and Methods of Use Jan 29, 2009 Abandoned
Array ( [id] => 7742438 [patent_doc_number] => 20120021043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant' [patent_app_type] => utility [patent_app_number] => 12/672442 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37845 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021043.pdf [firstpage_image] =>[orig_patent_app_number] => 12672442 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/672442
Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant Jan 27, 2009 Issued
Array ( [id] => 5435605 [patent_doc_number] => 20090170192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS AND DNA CONSTRUCTS FOR HIGH YIELD PRODUCTION OF POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/358966 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27206 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170192.pdf [firstpage_image] =>[orig_patent_app_number] => 12358966 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/358966
Methods and DNA constructs for high yield production of polypeptides Jan 22, 2009 Issued
Array ( [id] => 10026270 [patent_doc_number] => 09068160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Methods of producing an antisense viral particle population' [patent_app_type] => utility [patent_app_number] => 12/863351 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4797 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/863351
Methods of producing an antisense viral particle population Jan 15, 2009 Issued
Array ( [id] => 5392124 [patent_doc_number] => 20090209437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'TEMPERATURE REGULATED PROMOTERS FROM SCHIZOSACCHAROMYCES POMBE FOR EXPRESSION OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/329167 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7920 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209437.pdf [firstpage_image] =>[orig_patent_app_number] => 12329167 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/329167
TEMPERATURE REGULATED PROMOTERS FROM SCHIZOSACCHAROMYCES POMBE FOR EXPRESSION OF PROTEINS Dec 4, 2008 Abandoned
Array ( [id] => 6270467 [patent_doc_number] => 20100254947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/744375 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22708 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254947.pdf [firstpage_image] =>[orig_patent_app_number] => 12744375 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/744375
Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof Nov 23, 2008 Issued
Array ( [id] => 6270467 [patent_doc_number] => 20100254947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/744375 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22708 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254947.pdf [firstpage_image] =>[orig_patent_app_number] => 12744375 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/744375
Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof Nov 23, 2008 Issued
Array ( [id] => 6339691 [patent_doc_number] => 20100247490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38' [patent_app_type] => utility [patent_app_number] => 12/744441 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22328 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247490.pdf [firstpage_image] =>[orig_patent_app_number] => 12744441 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/744441
Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 Nov 23, 2008 Issued
Array ( [id] => 6270467 [patent_doc_number] => 20100254947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/744375 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22708 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254947.pdf [firstpage_image] =>[orig_patent_app_number] => 12744375 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/744375
Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof Nov 23, 2008 Issued
Array ( [id] => 9375971 [patent_doc_number] => 08680236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Altered OspA of borrelia burgdorferi ' [patent_app_type] => utility [patent_app_number] => 12/313443 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 138 [patent_figures_cnt] => 142 [patent_no_of_words] => 24244 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12313443 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/313443
Altered OspA of borrelia burgdorferi Nov 18, 2008 Issued
Array ( [id] => 9286013 [patent_doc_number] => 08642341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Materials and methods for gene mediated therapy of psychiatric disorders' [patent_app_type] => utility [patent_app_number] => 12/740725 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 8977 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740725 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/740725
Materials and methods for gene mediated therapy of psychiatric disorders Oct 30, 2008 Issued
Array ( [id] => 5391724 [patent_doc_number] => 20090209037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Viral core protein-cationic lipid-nucleic acid-delivery complexes' [patent_app_type] => utility [patent_app_number] => 12/261999 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209037.pdf [firstpage_image] =>[orig_patent_app_number] => 12261999 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/261999
Viral core protein-cationic lipid-nucleic acid-delivery complexes Oct 29, 2008 Abandoned
Array ( [id] => 5409570 [patent_doc_number] => 20090123468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM' [patent_app_type] => utility [patent_app_number] => 12/253138 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12023 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123468.pdf [firstpage_image] =>[orig_patent_app_number] => 12253138 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/253138
TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM Oct 15, 2008 Abandoned
Array ( [id] => 5374227 [patent_doc_number] => 20090311788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'MULTIPLE-COMPARTMENT EUKARYOTIC EXPRESSION SYSTEMS' [patent_app_type] => utility [patent_app_number] => 12/245431 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35617 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311788.pdf [firstpage_image] =>[orig_patent_app_number] => 12245431 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/245431
MULTIPLE-COMPARTMENT EUKARYOTIC EXPRESSION SYSTEMS Oct 2, 2008 Abandoned
Array ( [id] => 9711051 [patent_doc_number] => 08835621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Synthetic 5\'UTRs, expression vectors, and methods for increasing transgene expression' [patent_app_type] => utility [patent_app_number] => 12/681609 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 16631 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681609 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/681609
Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression Sep 25, 2008 Issued
Array ( [id] => 6623242 [patent_doc_number] => 20100311123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'VECTOR FOR EXPRESSING ANTIBODY FRAGMENTS AND A METHOD FOR PRODUCING RECOMBINANT PHAGE THAT DISPLAYS ANTIBODY FRAGMENTS BY USING THE VECTOR' [patent_app_type] => utility [patent_app_number] => 12/682880 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14583 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311123.pdf [firstpage_image] =>[orig_patent_app_number] => 12682880 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682880
VECTOR FOR EXPRESSING ANTIBODY FRAGMENTS AND A METHOD FOR PRODUCING RECOMBINANT PHAGE THAT DISPLAYS ANTIBODY FRAGMENTS BY USING THE VECTOR Sep 3, 2008 Abandoned
Array ( [id] => 5428102 [patent_doc_number] => 20090087412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression' [patent_app_type] => utility [patent_app_number] => 12/231311 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29053 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087412.pdf [firstpage_image] =>[orig_patent_app_number] => 12231311 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/231311
Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression Sep 1, 2008 Abandoned
Array ( [id] => 9523600 [patent_doc_number] => 08747861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Multimeric multiepitope influenza vaccines' [patent_app_type] => utility [patent_app_number] => 12/671617 [patent_app_country] => US [patent_app_date] => 2008-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 16379 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671617 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671617
Multimeric multiepitope influenza vaccines Aug 2, 2008 Issued
Menu